Photo from wikipedia
To evaluate the effect of addition of ruxolitinib in Graft‐versus‐Host Disease (GVHD) prophylaxis on pediatric patients with β‐thalassemia major after allogeneic hematopoietic stem cell transplantation(HSCT). Click to show full abstract
To evaluate the effect of addition of ruxolitinib in Graft‐versus‐Host Disease (GVHD) prophylaxis on pediatric patients with β‐thalassemia major after allogeneic hematopoietic stem cell transplantation(HSCT).
Keywords:
host disease;
versus host;
ruxolitinib graft;
transplantation;
addition ruxolitinib;
graft versus
Journal Title: Pediatric Transplantation
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Pediatric Transplantation
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!